John Lowry
Psychiatry · San Diego, CANPI 1477661619
Payments from drug & device makers
Across 640 payments — averaging $15.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$2K
- Sunovion Pharmaceuticals Inc.$1K
- AbbVie$1K
- Takeda Pharmaceuticals U.S.A., Inc.$886
- Alkermes, Inc.$856
- Neurocrine Biosciences, Inc.$785
- plus $3K from 16 others
What the payments were for
- Food & beverage$10,017100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 166 | $2,123 |
| Sunovion Pharmaceuticals Inc. | 141 | $1,457 |
| AbbVie(2 entities) | 66 | $1,225 |
| Takeda Pharmaceuticals U.S.A., Inc. | 47 | $886 |
| Alkermes, Inc. | 41 | $856 |
| Neurocrine Biosciences, Inc. | 37 | $785 |
| Corium, LLC | 33 | $622 |
| Ironshore Pharmaceuticals Inc. | 20 | $300 |
| Tris Pharma Inc | 12 | $241 |
| Otsuka America Pharmaceutical, Inc. | 11 | $217 |
| Lundbeck LLC | 8 | $182 |
| Vanda Pharmaceuticals Inc. | 6 | $167 |
| Johnson & Johnson | 6 | $155 |
| Vertical Pharmaceuticals, LLC | 11 | $152 |
| Shire North American Group Inc | 9 | $141 |
| Collegium Pharmaceutical, Inc. | 6 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 6 | $108 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $96 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Neos Therapeutics, LP | 1 | $25 |
| Bausch Health US, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- QELBREE$183
How this compares
$10,034 in reported general payments places this provider in the 90th percentile of 4,954 psychiatry providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 63 | $15,965 |
| Aripiprazole | 228 | $15,659 |
| Quetiapine Fumarate | 306 | $8,567 |
| VyvanseLisdexamfetamine Dimesylate | 20 | $8,192 |
| Chlorpromazine Hcl | 20 | $7,395 |
| Risperidone | 237 | $4,989 |
| Ziprasidone Hcl | 59 | $2,919 |
| Buspirone Hcl | 170 | $2,780 |
| Sertraline Hcl | 167 | $2,734 |
| Benztropine Mesylate | 217 | $2,507 |
| Clonazepam | 201 | $2,274 |
| Divalproex Sodium ErDivalproex Sodium | 38 | $1,958 |
| Olanzapine | 114 | $1,863 |
| Trazodone Hcl | 153 | $1,577 |
| Divalproex Sodium | 73 | $1,495 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $886 | $8,19220 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,954 psychiatry providers in California.
Other psychiatry in San Diego
- Eric ChavezSan Diego$15.5M
- Charmaine SemeniukSan Diego$8.9M
- Jonathan MeyerSan Diego$2.3M
- Vishaal MehraSan Diego$1M
- Elly LeeIrvine$49.8M
- Daniel ChuehOrange$17.9M
- Lara ShirikjianTorrance$12.6M
- John DuffySanta Ana$12M
- Marina BusselPlaya Vista$12M
- Sherry SoefjeOceanside$11.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.